Your browser doesn't support javascript.
loading
Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: the EU-GEI study.
Aas, Monica; Alameda, Luis; Di Forti, Marta; Quattrone, Diego; Dazzan, Paola; Trotta, Antonella; Ferraro, Laura; Rodriguez, Victoria; Vassos, Evangelos; Sham, Pak; Tripoli, Giada; Cascia, Caterina La; Barbera, Daniele La; Tarricone, Ilaria; Muratori, Roberto; Berardi, Domenico; Lasalvia, Antonio; Tosato, Sarah; Szöke, Andrei; Llorca, Pierre-Michel; Arango, Celso; Tortelli, Andrea; de Haan, Lieuwe; Velthorst, Eva; Bobes, Julio; Bernardo, Miguel; Sanjuán, Julio; Santos, Jose Luis; Arrojo, Manuel; Del-Ben, Cristina Marta; Menezes, Paulo Rossi; Selten, Jean-Paul; Jones, Peter B; Jongsma, Hannah E; Kirkbride, James B; Rutten, Bart P F; van Os, Jim; Gayer-Anderson, Charlotte; Murray, Robin M; Morgan, Craig.
Afiliación
  • Aas M; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8AF, UK.
  • Alameda L; Norment, Oslo University Hospital, Oslo, Norway.
  • Di Forti M; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8AF, UK.
  • Quattrone D; Service of General Psychiatry, Treatment and Early Intervention in Psychosis Program, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Dazzan P; Instituto de Investigación Biomédica de Sevilla, Universidad de Sevilla, Seville, Spain.
  • Trotta A; Department of Psychiatry, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Sevilla, Spain.
  • Ferraro L; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AE, UK.
  • Rodriguez V; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AE, UK.
  • Vassos E; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8AF, UK.
  • Sham P; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8AF, UK.
  • Tripoli G; Biomedicine, Neuroscience and Advanced Diagnostic (BiND) Department, University of Palermo, Palermo, Italy.
  • Cascia C; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8AF, UK.
  • Barbera D; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AE, UK.
  • Tarricone I; Department of Psychiatry, University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Muratori R; Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8AF, UK.
  • Berardi D; Biomedicine, Neuroscience and Advanced Diagnostic (BiND) Department, University of Palermo, Palermo, Italy.
  • Lasalvia A; Biomedicine, Neuroscience and Advanced Diagnostic (BiND) Department, University of Palermo, Palermo, Italy.
  • Tosato S; Biomedicine, Neuroscience and Advanced Diagnostic (BiND) Department, University of Palermo, Palermo, Italy.
  • Szöke A; Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, 40126 Bologna, Italy.
  • Llorca PM; Department of Mental Health and Pathological Addiction, Bologna Local Health Authority, Bologna, Italy.
  • Arango C; Department of Biomedical and Neuro-motor Sciences, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, 40126 Bologna, Italy.
  • Tortelli A; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.
  • de Haan L; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.
  • Velthorst E; INSERM U955, Equipe 15, Institut National de la Santé et de la Recherche Médicale, 94010 Créteil, France.
  • Bobes J; CMPB CHU Clermont-Ferrand, EA 7280, University Clermont Auvergne, Clermont-Ferrand, France.
  • Bernardo M; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM (CIBERSAM), 28007 Madrid, Spain.
  • Sanjuán J; Etablissement Public de Santé Maison Blanche, 75020 Paris, France.
  • Santos JL; Department of Psychiatry, Early Psychosis Section, Amsterdam UMC, Location: Academic Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Arrojo M; Department of Psychiatry, Early Psychosis Section, Amsterdam UMC, Location: Academic Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Del-Ben CM; Department of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, USA.
  • Menezes PR; Faculty of Medicine and Health Sciences - Psychiatry, Universidad de Oviedo, ISPA, INEUROPA, CIBERSAM, 33006 Oviedo, Spain.
  • Selten JP; Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, University of Barcelona; IDIBAPS, CIBERSAM, 08036 Barcelona, Spain.
  • Jones PB; Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), 46010 Valencia, Spain.
  • Jongsma HE; Department of Psychiatry, Servicio de Psiquiatría Hospital 'Virgen de la Luz', 16002 Cuenca, Spain.
  • Kirkbride JB; Department of Psychiatry, Psychiatry Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
  • Rutten BPF; Division of Psychiatry, Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, São Paulo 14049-900, Brazil.
  • van Os J; Department of Preventative Medicine, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo 01246-903, Brazil.
  • Gayer-Anderson C; Rivierduinen Institute for Mental Health Care, 2333 ZZ Leiden, The Netherlands.
  • Murray RM; Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, UK.
  • Morgan C; Psylife Group, Division of Psychiatry, University College London, London W1T 7NF, UK.
Psychol Med ; 53(5): 1970-1978, 2023 04.
Article en En | MEDLINE | ID: mdl-37310339
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Experiencias Adversas de la Infancia Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Psychol Med Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Experiencias Adversas de la Infancia Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Psychol Med Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido